Poland
Ardigen, founded in 2015, stands out in the burgeoning field of precision medicine by leveraging Artificial Intelligence and bioinformatics. Operating as an AI-driven data-to-insights partner, the company supports life science organizations in navigating the complexities of modern, multimodal drug discovery.
By constructing AI-ready biomedical data foundations, Ardigen has tailored its offerings to span the entire drug discovery and development lifecycle. From target identification to clinical and regulatory stages, its solutions are applicable across diverse therapeutic areas. Central to its process is a biological and scientific alignment, which ensures that analytical approaches are rooted in research objectives, enabling improved data-driven decision-making.
Ardigen has proven its capability through over 700+ discovery projects, trusted by global leaders in the pharmaceutical and biotech sectors. Its modular delivery model, designed to align with clients' data maturity, brings fragmented datasets into cohesive, scalable workflows, expediting the drug discovery process while reducing R&D risk.
